Full-Time

Business Development Manager

Updated on 5/8/2024

Quanterix

Quanterix

201-500 employees

Ultrasensitive biomarker detection technology

Data & Analytics

Mid

New York, NY, USA

Required Skills
Sales
Requirements
  • 3-5 years of capital equipment sales in the life sciences industry
  • Master’s degree in relevant Science field, Engineering, Cell Biology, Biology, Molecular Biology, Biochemistry, Chemistry
  • Technical skill and experience in Immunoassay/Flow/Imaging with capital equipment sales
  • Must live in NY, NJ, CT
  • Valid Driver's license
Responsibilities
  • Serve as the Sales Executive for the Simoa platforms and all reagents
  • Relentlessly pursue Capital Equipment sales activities to create and close opportunities
  • Leverage existing database of contacts to expand Quanterix’s customer base
  • Possess a hunter's mentality in generating leads and building a pipeline
  • Utilize the ONE TEAM approach with local FAS & FSE to demonstrate clear product/technology expertise
  • Utilize account radiate strategies to expand base of business across key functional groups
  • Manage the sales cycle from introduction through purchase to deployment
  • Coordinate, prepare and compile tender submission documents
  • Field travel as necessary in your target territory

Quanterix represents a pioneer in the biotechnology industry, providing Simoa technology that utilizes advanced microarray printer and ultrasensitive immunoassay platforms. This technology enables ultra-sensitive biomarker detection, facilitating early disease diagnosis and precise treatment in critical areas such as oncology and neurology. The company’s dedication to advancing healthcare through technological prowess makes it an excellent workplace for professionals passionate about impactful innovation and contributing to significant medical advancements.

Company Stage

IPO

Total Funding

$559.6M

Headquarters

Billerica, Massachusetts

Founded

2007

Growth & Insights
Headcount

6 month growth

9%

1 year growth

20%

2 year growth

-7%